•  
  •  
  •  
  •  

2025-09-02 21:18:21

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • NDTV Board approves Rights Issue of upto INR 400 Crore
  • Cupid Limited Robust B2B Export Order Book & Encouraging International Order Pipeline
  • PNC Infratech Ltd emerges L1 bidder for AAI tender
  • ITCONS E-Solutions Limited bags contract
  • SDHI & Indian Maritime University sign MoU to launch maritime Centres of Excellence, specialized workforce training programmes

Keywords Selected:  IpcaLaboratories

Research

  • BUY Ipca Laboratories - Q4FY22 Result Update - Weak exports; gradual recovery

Stock Report

  • Ipca Laboratories Ltd enters into technology transfer agreement with Omexa Formulary Pvt Ltd
  • IPCA Laboratories Ltd Q1 FY2024 consolidated net profit at Rs. 162.82 crores
  • Ipca Laboratories Ltd receives 8 observations from USFDA for formulations facility at SEZ Indore, Pithampur
  • Ipca Laboratories Ltd gets Form 483 with 11 observations for API manufacturing facility at Ratlam
  • Income Tax Survey at Ipca Laboratories Ltd's plants
  • IPCA Laboratories Ltd posts lower consolidated Q4FY23 net profit of Rs. 76.52 crores
  • Ipca Laboratories Limited gets 3 observations for Piparia, Silvassa unit
  • Ipca Laboratories Ltd to acquire majority stake in Unichem Laboratories Ltd
  • Lyka Labs Limited allots 24 lakh shares on conversion of warrants to Ipca Laboratories Ltd
  • Lyka Labs Ltd approves preferential issue to IPCA Laboratories Ltd
  • Ipca Laboratories Limited increases stake in Nutricharge
  • Ipca Laboratories Ltd commissions second plant at Dewas
  • IPCA Laboratories Ltd consolidated Q1 FY23 PAT up QoQ at Rs. 143.06 crores
  • IPCA Laboratories posts Rs. 130.23 crores consolidated profit in Q4FY22
  • IPCA Laboratories Q3FY22 consolidated PAT at Rs. 196.96 crores
  • Krebs Biochemicals & Industries Limited board approves allotment of RNNCPS to IPCA Laboratories Ltd
  • IPCA Laboratories Ltd fixes Jan 11, 2022 as record date for stock split
  • Krebs Biochemicals & Industries Ltd board approves issue of preference shares

Latest Post

  • NDTV Board approves Rights Issue of upto INR 400 Crore
  • Cupid Limited Robust B2B Export Order Book & Encouraging International Order Pipeline
  • PNC Infratech Ltd emerges L1 bidder for AAI tender
  • ITCONS E-Solutions Limited bags contract
  • SDHI & Indian Maritime University sign MoU to launch maritime Centres of Excellence, specialized workforce training programmes


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024